Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Cath Lab

Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths

April 9, 2019 — A program designed to help heart attack patients with the transition from hospital to outpatient care ...

April 09, 2019

News | Heart Valve Technology | Jeff Zagoudis, Associate Editor

Mick Jagger Recovering After TAVR Procedure

April 8, 2019 — Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic ...

April 08, 2019

Technology | Cath Lab

TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy

April 8, 2019 — TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for ...

April 08, 2019

Sponsored Content

Blog | Contrast Media Injectors

BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

August 22, 2023

News | Ventricular Assist Devices (VAD)

Cardiogenic Shock Survival Rates Improve in Three Years Since Impella FDA Approval

April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...

April 05, 2019

Technology | Radiation Dose Management

Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction

April 4, 2019 — The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer ...

April 04, 2019

Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting

News | Heart Valve Technology

TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

April 03, 2019

Sponsored Content

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Blog | Enterprise Imaging

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

August 10, 2023

The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral Vascular's Covera Vascular Covered Stent for the treatment of a stenosis or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an arteriovenous (AV) fistula.

Technology | Stents

New Indication Added for Covered Stent to Treat Hemodialysis AV Fistula

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

April 03, 2019

The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.

Technology | Venous Therapies

FDA Clears Venous Stent for the Iliofemoral Veins

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

April 03, 2019

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.

Technology | Vascular Closure Devices

Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

April 03, 2019

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions.

Technology

Resolute Integrity Now Indicated for CTOs

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

April 03, 2019

The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.

Feature

April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...

April 01, 2019

All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.

Feature | Structural Heart | Jeff Zagoudis

The Essentials of Structural Heart Imaging

Structural heart interventions represent one of the fastest growing segments of cardiology, as the number of devices to ...

March 28, 2019

Sponsored Content

Blog | Intra-Vascular Ultrasound (IVUS)

BLOG: Making a Case for the Variable Rate Contrast Injector

During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...

April 11, 2023

Videos

VIDEO: The Role of the NCDR in Boosting Cardiology Quality Improvement

Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and ...

March 28, 2019

News | Stroke

New Stroke Training Model Improves Access to Life-Saving Care

March 27, 2019 — Training interventional radiologists to perform endovascular thrombectomies results in positive ...

March 27, 2019

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

Feature | ACC | Greg Freiherr, Contributing Editor

New Technology Highlights on the ACC 2019 Exhibit Floor

The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...

March 27, 2019